Aurinia Pharmaceuticals Inc. financial data

Symbol
AUPH on Nasdaq
Industry
Pharmaceutical Preparations
Location
#140, 14315 118 Avenue, Edmonton, Alberta, Canada
Fiscal year end
December 31
Latest financial report
10-K - Q4 2024 - Feb 27, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 523 % -21.3%
Quick Ratio 48.3 % -10.5%
Debt-to-equity 43.7 % +23%
Return On Equity 1.54 %
Return On Assets 1.08 %
Operating Margin -1.99 % +96.2%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 137M shares -3.97%
Common Stock, Shares, Outstanding 141M shares -2.05%
Entity Public Float 800M USD -42%
Weighted Average Number of Shares Outstanding, Basic 143M shares -0.13%
Weighted Average Number of Shares Outstanding, Diluted 146M shares +2.07%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 235M USD +34%
Cost of Revenue 28.2M USD +99.7%
Research and Development Expense 20.8M USD -58.1%
General and Administrative Expense 172M USD -11.8%
Costs and Expenses 240M USD -10.2%
Operating Income (Loss) -4.69M USD +94.9%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 7.45M USD
Income Tax Expense (Benefit) 1.7M USD +208%
Net Income (Loss) Attributable to Parent 5.75M USD
Earnings Per Share, Basic 0.05 USD/shares
Earnings Per Share, Diluted 0.05 USD/shares

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 83.4M USD +71.1%
Inventory, Net 39.2M USD -1.2%
Other Assets, Current 1.13M USD +9.51%
Assets, Current 447M USD +5.13%
Property, Plant and Equipment, Net 2.73M USD -18.6%
Operating Lease, Right-of-Use Asset 4.07M USD -9.56%
Other Assets, Noncurrent 823K USD -45.7%
Assets 551M USD +0.47%
Accounts Payable, Current 5.19M USD +19.9%
Employee-related Liabilities, Current 18.6M USD -17.1%
Accrued Liabilities, Current 65M USD +29.8%
Contract with Customer, Liability, Current 11M USD +129%
Liabilities, Current 97.8M USD +26.7%
Operating Lease, Liability, Noncurrent 5.74M USD -12.1%
Other Liabilities, Noncurrent 11.1M USD +1.8%
Liabilities 173M USD +1.8%
Accumulated Other Comprehensive Income (Loss), Net of Tax -647K USD +11.4%
Retained Earnings (Accumulated Deficit) -937M USD +0.61%
Stockholders' Equity Attributable to Parent 377M USD -0.13%
Liabilities and Equity 551M USD +0.47%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -18.6M USD +41.3%
Net Cash Provided by (Used in) Financing Activities -15.1M USD -1018%
Net Cash Provided by (Used in) Investing Activities 49.2M USD +98%
Common Stock, Shares, Issued 141M shares -2.05%
Common Stock, Par or Stated Value Per Share 0 USD/shares
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 15.6M USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 83.4M USD +70.7%
Deferred Tax Assets, Valuation Allowance 154M USD -4.61%
Deferred Tax Assets, Gross 169M USD -7.67%
Operating Lease, Liability 6.77M USD -9.98%
Depreciation 4.85M USD +576%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent 5.84M USD
Lessee, Operating Lease, Liability, to be Paid 8.03M USD -12.3%
Property, Plant and Equipment, Gross 5.26M USD 0%
Operating Lease, Liability, Current 1.03M USD +3.74%
Lessee, Operating Lease, Liability, to be Paid, Year Two 1.17M USD +2.19%
Lessee, Operating Lease, Liability, to be Paid, Year One 1.14M USD +2.24%
Operating Lease, Weighted Average Discount Rate, Percent 0.05 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 1.26M USD -23%
Lessee, Operating Lease, Liability, to be Paid, Year Three 1.2M USD +2.22%
Deferred Tax Assets, Operating Loss Carryforwards 130M USD -5.63%
Lessee, Operating Lease, Liability, to be Paid, Year Four 1.23M USD +2.17%
Operating Lease, Payments 276K USD +4.94%
Amortization of Intangible Assets 900K USD -47.1%
Deferred Tax Assets, Net of Valuation Allowance 14.1M USD -31.6%
Share-based Payment Arrangement, Expense 31.6M USD -30.3%
Interest Expense 5.19M USD +1743%